Artigos de revistas sobre o tema "Cer-001"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 45 melhores artigos de revistas para estudos sobre o assunto "Cer-001".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Zheng, Kang He, Fleur M. van der Valk, Loek P. Smits, Mara Sandberg, Jean-Louis Dasseux, Rudi Baron, Ronald Barbaras et al. "HDL mimetic CER-001 targets atherosclerotic plaques in patients". Atherosclerosis 251 (agosto de 2016): 381–88. http://dx.doi.org/10.1016/j.atherosclerosis.2016.05.038.
Texto completo da fonteOssoli, A., A. Strazzella, S. Simonelli, D. Rottoli, M. Abbate, C. M. Zoja, J. L. Dasseux e L. Calabresi. "Remodeling And Catabolism Of Cer-001 In Absence Of Lcat Enzyme". Atherosclerosis 287 (agosto de 2019): e107. http://dx.doi.org/10.1016/j.atherosclerosis.2019.06.312.
Texto completo da fonteKeyserling, Constance H., Ronald Barbaras, Renee Benghozi e Jean-Louis Dasseux. "Development of CER-001: Preclinical Dose Selection Through to Phase I Clinical Findings". Clinical Drug Investigation 37, n.º 5 (17 de fevereiro de 2017): 483–91. http://dx.doi.org/10.1007/s40261-017-0506-3.
Texto completo da fonteNicholls, Stephen J., Jordan Andrews, John J. P. Kastelein, Bela Merkely, Steven E. Nissen, Kausik K. Ray, Gregory G. Schwartz et al. "Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial". JAMA Cardiology 3, n.º 9 (1 de setembro de 2018): 815. http://dx.doi.org/10.1001/jamacardio.2018.2121.
Texto completo da fonteLi, Chen, Pan Pan Wu e Kun Zhang. "Preparaitve Separation and Purification of Cordycepin from Cultured Cordyceps militaris Using Cation Exchange Resin". Advanced Materials Research 550-553 (julho de 2012): 1773–78. http://dx.doi.org/10.4028/www.scientific.net/amr.550-553.1773.
Texto completo da fonteFlores-Peña, Yolanda, María Eugenia Pérez-Campa, Hermelinda Ávila-Alpirez, Juana Mercedes Gutiérrez-Valverde e Gustavo Gutiérrez-Sánchez. "Depressive symptoms, maternal feeding styles, and preschool child’s body weight". Salud mental 44, n.º 6 (2 de dezembro de 2021): 261–66. http://dx.doi.org/10.17711/sm.0185-3325.2021.034.
Texto completo da fonteFaguer, Stanislas, Magali Colombat, Dominique Chauveau, Pauline Bernadet-Monrozies, Audrey Beq, Audrey Delas, Vincent Soler et al. "Administration of the High-Density Lipoprotein Mimetic CER-001 for Inherited Lecithin–Cholesterol Acyltransferase Deficiency". Annals of Internal Medicine 174, n.º 7 (julho de 2021): 1022–25. http://dx.doi.org/10.7326/l20-1300.
Texto completo da fonteNicholls, Stephen J., Jordan Andrews, John Jp Kastelein, Bela Merkely, Steven E. Nissen, Kausik Ray, Gregory G. Schwartz et al. "CARAT: will infusing a pre-beta high-density lipoprotein mimetic (CER-001) regress coronary atherosclerosis?" Atherosclerosis 263 (agosto de 2017): e10. http://dx.doi.org/10.1016/j.atherosclerosis.2017.06.060.
Texto completo da fonteOssoli, A., A. Strazzella, D. Rottoli, C. Zanchi, M. Locatelli, C. Zoja, S. Simonelli et al. "CER-001 ameliorates lipid profile and kidney disease in a mouse model of familial LCAT deficiency". Atherosclerosis 331 (agosto de 2021): e39. http://dx.doi.org/10.1016/j.atherosclerosis.2021.06.112.
Texto completo da fonteFaguer, S., M. Colombat, D. Chauveau, P. Bernadet, A. Delas, V. Soler, I. Labadens, A. Huart e J. Schanstra. "Place du mimétique HDL CER-001 dans la glomérulopathie secondaire aux déficits en lécithine-cholestérol acyltransférase (LCAT)". Néphrologie & Thérapeutique 17, n.º 5 (setembro de 2021): 317–18. http://dx.doi.org/10.1016/j.nephro.2021.07.182.
Texto completo da fontePavanello, Chiara, Marta Turri, Arianna Strazzella, Patrizia Tulissi, Stefano Pizzolitto, Giovanna De Maglio, Riccardo Nappi, Laura Calabresi e Giuliano Boscutti. "The HDL mimetic CER‐001 remodels plasma lipoproteins and reduces kidney lipid deposits in inherited lecithin:cholesterol acyltransferase deficiency". Journal of Internal Medicine 291, n.º 3 (11 de novembro de 2021): 364–70. http://dx.doi.org/10.1111/joim.13404.
Texto completo da fonteZheng, Kang H., Yannick Kaiser, Casper C. van Olden, Raul D. Santos, Jean-Louis Dasseux, Jacques Genest, Daniel Gaudet et al. "No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels". Atherosclerosis 311 (outubro de 2020): 13–19. http://dx.doi.org/10.1016/j.atherosclerosis.2020.08.004.
Texto completo da fonteTardy, Claudine, Marine Goffinet, Nadia Boubekeur, Guy Cholez, Rose Ackermann, Gavin Sy, Constance Keyserling et al. "HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation". PLOS ONE 10, n.º 9 (3 de setembro de 2015): e0137584. http://dx.doi.org/10.1371/journal.pone.0137584.
Texto completo da fonteLawrence, Caroline, Erica E. Fortune, Heather Badt, Kara Doughtie, Madyson L. Popalis e Melissa F. Miller. "Abstract P4-05-01: Cancer-Related Distress and Unmet Needs Among Triple Negative Breast Cancer Patients: Findings from the Cancer Experience Registry". Cancer Research 83, n.º 5_Supplement (1 de março de 2023): P4–05–01—P4–05–01. http://dx.doi.org/10.1158/1538-7445.sabcs22-p4-05-01.
Texto completo da fonteAndrews, Jordan, Alex Janssan, Tracy Nguyen, Anthony D. Pisaniello, Daniel J. Scherer, John J. P. Kastelein, Bela Merkely et al. "Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study". Cardiovascular Diagnosis and Therapy 7, n.º 1 (fevereiro de 2017): 45–51. http://dx.doi.org/10.21037/cdt.2017.01.01.
Texto completo da fonteKataoka, Yu, Jordan Andrews, MyNgan Duong, Tracy Nguyen, Nisha Schwarz, Jessica Fendler, Rishi Puri et al. "Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burden". Cardiovascular Diagnosis and Therapy 7, n.º 3 (junho de 2017): 252–63. http://dx.doi.org/10.21037/cdt.2017.02.01.
Texto completo da fonteHovingh, G. K., E. S. Stroes, D. Gaudet, C. Stefanutti, H. Soran, S. Kwok, J. de Graaf et al. "Effects of CER-001 on carotid atherosclerosis by 3tmri in homozygous familial hypercholesterolemia (HoFH): The modifying orphan disease evaluation (mode) study". Atherosclerosis 235, n.º 2 (agosto de 2014): e13-e14. http://dx.doi.org/10.1016/j.atherosclerosis.2014.05.008.
Texto completo da fonteTardif, J. C., C. M. Ballantyne, P. Barter, J. L. Dasseux, Z. A. Fayad, M. C. Guertin, J. J. P. Kastelein et al. "Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial". European Heart Journal 35, n.º 46 (29 de abril de 2014): 3277–86. http://dx.doi.org/10.1093/eurheartj/ehu171.
Texto completo da fonteTardy, Claudine, Marine Goffinet, Nadia Boubekeur, Rose Ackermann, Gavin Sy, Alice Bluteau, Guy Cholez et al. "CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice". Atherosclerosis 232, n.º 1 (janeiro de 2014): 110–18. http://dx.doi.org/10.1016/j.atherosclerosis.2013.10.018.
Texto completo da fonteFranzin, Rossana, Alessandra Stasi, Marco Fiorentino, Irene Scalera, Monica Campioni, Maria Teresa Cimmarusti, Giuseppe Castellano et al. "CER-001, a Recombinant HDL, Modulates Ischemia/Reperfusion Injury (IRI) in Hypothermic (HMP) and Normothermic Perfusion (NMP) Solutions Through pAKT/eNOS Activation". Journal of the American Society of Nephrology 34, n.º 11S (novembro de 2023): 23. http://dx.doi.org/10.1681/asn.20233411s123c.
Texto completo da fonteKootte, Ruud S., Loek P. Smits, Fleur M. van der Valk, Jean-Louis Dasseux, Constance H. Keyserling, Ronald Barbaras, John F. Paolini et al. "Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA". Journal of Lipid Research 56, n.º 3 (5 de janeiro de 2015): 703–12. http://dx.doi.org/10.1194/jlr.m055665.
Texto completo da fonteKootte, R. S., L. P. Smits, F. M. van der Valk, J. L. Dasseux, C. Keyserling, R. Barbaras, J. Paolini et al. "Recombinant human apolipoprotein-a-i prebeta-HDL (cer-001) promotes reverse cholesterol transport and reduces carotid wall thickness in patients with genetically-determined low HDL". Atherosclerosis 235, n.º 2 (agosto de 2014): e14. http://dx.doi.org/10.1016/j.atherosclerosis.2014.05.009.
Texto completo da fonteHovingh, G. Kees, Loek P. Smits, Claudia Stefanutti, Handrean Soran, See Kwok, Jacqueline de Graaf, Daniel Gaudet et al. "The effect of an apolipoprotein A-I–containing high-density lipoprotein–mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia". American Heart Journal 169, n.º 5 (maio de 2015): 736–42. http://dx.doi.org/10.1016/j.ahj.2015.01.008.
Texto completo da fonteStroes, E., R. Benghozi, J. L. Dasseux, J. Genest, H. Ginsberg, C. Keyserling, E. Leitersdorf, P. Raggi e A. von Eckardstein. "A phase III multicentre, double-blind, placebo-controlled study (TANGO) to evaluate CER-001 on carotid atherosclerosis (vessel wall area) in patients with familial primary hypoalphalipoproteinaemia". Atherosclerosis 252 (setembro de 2016): e111-e112. http://dx.doi.org/10.1016/j.atherosclerosis.2016.07.609.
Texto completo da fonteLe, Loan, Daniel J. Schwartz, Risa Nakase-Richardson, Emily J. Almeida, William Anderson, Kevin Patel, Benjamin Sudolcan e Sagarika Nallu. "0556 Simultaneous comparison of unedited and manually edited HSAT with level 1 PSG in persons with hospitalized TBI". SLEEP 46, Supplement_1 (1 de maio de 2023): A245. http://dx.doi.org/10.1093/sleep/zsad077.0556.
Texto completo da fonteKnapik, Katarzyna, Karolina Sieroń, Ewa Wojtyna, Grzegorz Onik, Ewa Romuk, Ewa Birkner, Agata Stanek, Aleksandra Kawczyk-Krupka, Ryszard Plinta e Aleksander Sieroń. "Precompetitional Weight Reduction Modifies Prooxidative-Antioxidative Status in Judokas". Oxidative Medicine and Cellular Longevity 2019 (22 de julho de 2019): 1–9. http://dx.doi.org/10.1155/2019/2164698.
Texto completo da fonteCordeiro Juliani, Fabiana, Viviane Zorzanelli Rocha, Ana Paula Marte Chacra e Raul Dias dos Santos. "HIPOALFALIPOPROTEINEMIAS: DIAGNÓSTICO DIFERENCIAL, APRESENTAÇÃO CLÍNICA E DESAFIO TERAPÊUTICO". Revista da Sociedade de Cardiologia do Estado de São Paulo 31, n.º 1 (1 de abril de 2021): 23–31. http://dx.doi.org/10.29381/0103-8559/2021310123-31.
Texto completo da fonteDoughtie, Kara, Erica E. Fortune, Heather Badt, Caroline Lawrence, Madyson L. Popalis e Melissa F. Miller. "Abstract P6-05-29: Experience of Financial Toxicity and Distress Among Individuals Diagnosed with Triple Negative Breast Cancer: Findings from the Cancer Experience Registry". Cancer Research 83, n.º 5_Supplement (1 de março de 2023): P6–05–29—P6–05–29. http://dx.doi.org/10.1158/1538-7445.sabcs22-p6-05-29.
Texto completo da fonteKuandykova, Elvira, Bakhitzhan Kuandykov, Sabit Daubassov, Manshuk Beysenbaeva, Duman Kussainov e Bayan Ashyralieva. "Legal basis of international agricultural organizations". RIVISTA DI STUDI SULLA SOSTENIBILITA' 13, n.º 1 (novembro de 2023): 217–31. http://dx.doi.org/10.3280/riss2023-001-s1014.
Texto completo da fonteStrobel, Sabine, e Thomas Schleid. "Quaternäre Strontium-Kupfer(I)-Lanthanoid(III)-Selenide mit Cer und Praseodym: SrCuCeSe3 und SrCuPrSe3, ein ungleiches Geschwisterpaar / Quaternary Strontium Copper(I) Lanthanoid(III) Selenides with Cerium and Praseodymium: SrCuCeSe3 and SrCuPrSe3, Unequal Brother and Sister". Zeitschrift für Naturforschung B 59, n.º 9 (1 de setembro de 2004): 985–91. http://dx.doi.org/10.1515/znb-2004-0907.
Texto completo da fonteGoffinet, Marine, Claudine Tardy, Alice Bluteau, Nadia Boubekeur, Rudi Baron, Constance Keyserling, Ronald Barbaras, Narendra Lalwani e Jean-Louis Dasseux. "Abstract 18667: Anti-atherosclerotic Effect of CER-001, an Engineered HDL-mimetic, in the High-fat Diet-fed LDLr Knockout Mice". Circulation 126, suppl_21 (20 de novembro de 2012). http://dx.doi.org/10.1161/circ.126.suppl_21.a18667.
Texto completo da fonteStasi, Alessandra, Marco Fiorentino, Rossana Franzin, Francesco Staffieri, Sabrina Carparelli, Rosa Losapio, Alberto Crovace et al. "Beneficial effects of recombinant CER-001 high-density lipoprotein infusion in sepsis: results from a bench to bedside translational research project". BMC Medicine 21, n.º 1 (2 de novembro de 2023). http://dx.doi.org/10.1186/s12916-023-03057-5.
Texto completo da fonteBarbaras, Ronald. "Non-clinical development of CER-001". Frontiers in Pharmacology 6 (6 de outubro de 2015). http://dx.doi.org/10.3389/fphar.2015.00220.
Texto completo da fonteStasi, Alessandra, Rossana Franzin, Marco Fiorentino, Francesco Staffieri, Rosa Losapio, Maria Teresa Cimmarusti, Alberto Crovace et al. "#4015 RECOMBINANT HIGH-DENSITY LIPOPROTEIN MODULATES INFLAMMATORY RESPONSE AND RENAL DYSFUNCTION IN A SWINE MODEL OF SEPSIS-INDUCED ACUTE KIDNEY INJURY". Nephrology Dialysis Transplantation 38, Supplement_1 (junho de 2023). http://dx.doi.org/10.1093/ndt/gfad063a_4015.
Texto completo da fonteKalayci, Arzu, C. Michael Gibson, Paul M. Ridker, Samuel D. Wright, Bronwyn A. Kingwell, Serge Korjian, Gerald Chi et al. "ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future". Current Atherosclerosis Reports, 7 de maio de 2022. http://dx.doi.org/10.1007/s11883-022-01025-7.
Texto completo da fonteFranzin, Rossana, Alessandra Stasi, Marco Fiorentino, Fabio Sallustio, Ronald Barbaras, Connie Peyrottes, Cyrille Tupin, Giuseppe Castellano, Paola Pontrelli e Loreto Gesualdo. "MO287: A Recombinant BIO-HDL (CER-001) Can Prevent SARS-COV2-Induced Renal Dysfunction by Restoring SR-BI Signalling". Nephrology Dialysis Transplantation 37, Supplement_3 (maio de 2022). http://dx.doi.org/10.1093/ndt/gfac067.086.
Texto completo da fonteKataoka, Yu, Jordan Andrews, MyNgan Duong, Tracy Nguyen, Nisha Schwarz, Jessica Fendler, Rishi Puri et al. "Abstract 12156: Greater Regression of Coronary Atherosclerosis With the Pre-Beta High-Density Lipoprotein Mimetic CER-001 in Patients With More Extensive Plaque Burden". Circulation 132, suppl_3 (10 de novembro de 2015). http://dx.doi.org/10.1161/circ.132.suppl_3.12156.
Texto completo da fonteFaguer, Stanislas, Arnaud Del Bello, Chloé Danet, Yves Renaudineau, Jacques Izopet e Nassim Kamar. "Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study". Frontiers in Pharmacology 13 (26 de setembro de 2022). http://dx.doi.org/10.3389/fphar.2022.936659.
Texto completo da fonteWoodall, J. M. "Contactless Electromodulation Characterization of Compound Semiconductor Surfaces and Device Structures". MRS Proceedings 324 (1993). http://dx.doi.org/10.1557/proc-324-141.
Texto completo da fonteOssoli, Alice, Arianna Strazzella, Daniela Rottoli, Cristina Zanchi, Monica Locatelli, Carlamaria Zoja, Sara Simonelli et al. "CER-001 ameliorates lipid profile and kidney disease in a mouse model of Familial LCAT Deficiency". Metabolism, dezembro de 2020, 154464. http://dx.doi.org/10.1016/j.metabol.2020.154464.
Texto completo da fonteRomero, Natividad Calvo, Jesús Domínguez Delgado-Palacios, Marta Calvo Arevalo, Isabel Pérez-Flores, Beatriz Rodríguez Cubillo, María Ángeles Moreno de la Higuera Díaz, María Muñiz Rincón, Arianne Aiffil Meneses, Rómulo Katsu Loayza López e Ana Sanchez Fructuoso. "#5146 KINETIC ESTIMATION OF GFR AND URINARY CREATININE EXCRETION RATE AS PREDICTORS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANTS FROM DECEASED DONORS". Nephrology Dialysis Transplantation 38, Supplement_1 (junho de 2023). http://dx.doi.org/10.1093/ndt/gfad063c_5146.
Texto completo da fonteQing, Shuiwang, Lei Gu, Tingting Du, Xiaolan Yin, Ke-jia Zhang e Huo-jun Zhang. "A Predictive Model to Evaluate Pathologic Complete Response in Rectal Adenocarcinoma". Technology in Cancer Research & Treatment 22 (janeiro de 2023). http://dx.doi.org/10.1177/15330338231202893.
Texto completo da fonteGoto, Ken, Tomo Ueno e Yoshinao Kumagai. "Heterostructure formation of group-III sesquioxides via cation-exchange reactions with metal chloride gases". AIP Advances 13, n.º 8 (1 de agosto de 2023). http://dx.doi.org/10.1063/5.0143736.
Texto completo da fonteSrivastava, Rai Ajit K., Angelo B. Cefalu, Davide Noto, Donata Panno, Antonella Giammanco Giammanco e Maurizio R. Averna. "Abstract 9805: Lack of Correlation Between HDL Level and Fecal Cholesterol in Multiple Mouse Models Suggests Importance of HDL Functionality in Atherosclerosis Attenuation". Circulation 132, suppl_3 (10 de novembro de 2015). http://dx.doi.org/10.1161/circ.132.suppl_3.9805.
Texto completo da fonteDoebele, Robert C., Laura Perez, Huong Trinh, Michael Martinec, Reynaldo Martina, Todd Riehl, Matthew G. Krebs, Neal J. Meropol, William B. Wong e Gracy Crane. "Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data in ROS1+ NSCLC". Journal of Comparative Effectiveness Research, 24 de agosto de 2021. http://dx.doi.org/10.2217/cer-2021-0131.
Texto completo da fonte